Cepheid Reports Fourth Quarter And Full Year 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Leerink Partners Reiterates Market Perform on Cepheid (CPHD) Following 4Q
February 3, 2016 8:51 AM ESTLeerink Partners reiterated a Market Perform rating on Cepheid (NASDAQ: CPHD), and cut the price target to $33.00 (from $39.00), following the company's 4Q earnings report. CPHDs reported revenue of $147M was in-line with the Street's forecast of $147M. Higher-than-consensus clinical systems sales were offset... More
Cepheid (CPHD) Reports Q4 EPS of 7c, Offers FY16 Guidance
February 2, 2016 4:15 PM ESTCepheid (NASDAQ: CPHD) reported Q4 EPS of $0.07, may not compare to the analyst estimate of ($0.20). Revenue for the quarter came in at $147 million versus the consensus estimate of $146.91 million.
GUIDANCE:
Cepheid sees FY2016 EPS of $0.22-$0.28, may not compare to... More
